Does roflumilast induce phagocytic activity in COPD patients?

被引：0
|
作者：
Ghosh, Baishakhi [1 ,2 ]
Vanjare, Nitin V. [1 ]
机构：
[1] Chest Res Fdn, Pune 411014, Maharashtra, India
[2] Symbiosis Int Univ, Fac Hlth & Biomed Sci, Pune, Maharashtra, India
来源：
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015年 / 10卷
关键词：
OBSTRUCTIVE PULMONARY-DISEASE;
D O I：
10.2147/COPD.S92812
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial
    Lee, Sang-Do
    Hui, David S. C.
    Mahayiddin, Aziah A.
    Roa, Camilo C., Jr.
    Kwa, Kheng Hoe
    Goehring, Udo-Michael
    Bredenbroeker, Dirk
    Kuo, Han-Pin
    RESPIROLOGY, 2011, 16 (08) : 1249 - 1257
  • [32] Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations
    Field, Stephen K.
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2011, 5 : 57 - 70
  • [33] MICROBIAL GROWTH DOES NOT INFLUENCE THE PHAGOCYTIC DEFECT IN ALVEOLAR MACROPHAGES IN COPD
    Holt, P.
    Tran, H.
    Hodge, G.
    Reynolds, P.
    Hodge, S.
    RESPIROLOGY, 2014, 19 : 62 - 62
  • [34] The effect of roflumilast in addition to LABA/LAMA/ICS treatment in COPD patients
    De Backer, Wilfried
    Vos, Wim
    Van Holsbeke, Cedric
    Vinchurkar, Samir
    Claes, Rita
    Hufkens, Annemie
    Parizel, Paul M.
    Bedert, Lieven
    De Backer, Jan
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44 (02) : 527 - 529
  • [35] Inhaled β-agonist does not modify sympathetic activity in patients with COPD
    Helge Haarmann
    Cordula Mohrlang
    Uta Tschiesner
    David B Rubin
    Thore Bornemann
    Karin Rüter
    Slavtcho Bonev
    Tobias Raupach
    Gerd Hasenfuß
    Stefan Andreas
    BMC Pulmonary Medicine, 15
  • [36] Inhaled β-agonist does not modify sympathetic activity in patients with COPD
    Haarmann, Helge
    Mohrlang, Cordula
    Tschiesner, Uta
    Rubin, David B.
    Bornemann, Thore
    Rueter, Karin
    Bonev, Slavtcho
    Raupach, Tobias
    Hasenfuss, Gerd
    Andreas, Stefan
    BMC PULMONARY MEDICINE, 2015, 15
  • [37] EFFECT OF A DOSE ESCALATION REGIMEN TO IMPROVE ADHERENCE OF ROFLUMILAST IN PATIENTS WITH COPD
    Park, Jeong-Woong
    Hwang, Hyunjung
    Kim, Yu Jin
    Jeong, Sung Hwan
    RESPIROLOGY, 2015, 20 : 43 - 43
  • [38] Roflumilast reduziert Exazerbationen bei COPD
    MMW - Fortschritte der Medizin, 2012, 154 (12) : 72 - 72
  • [39] Fewer exacerbations with roflumilast in severe COPD
    Lyon, Sue
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (12) : 671 - 671
  • [40] Roflumilast-Glucocorticoid Synergy In COPD
    Reddy, A. T.
    Lakshmi, S. P.
    Reddy, R. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345